Effects of Roxithromycin on Tumor Necrosis Factor‐Alpha‐Induced Vascular Endothelial Growth Factor Expression in Human Periodontal Ligament Cells in Culture
- 1 October 2000
- journal article
- Published by Wiley in The Journal of Periodontology
- Vol. 71 (10), 1546-1553
- https://doi.org/10.1902/jop.2000.71.10.1546
Abstract
Aberrant angiogenesis is associated with lesion formation in chronic periodontitis. However, little is known about the mediators that contribute to angiogenesis or about therapeutic agents that control the production of the mediators. Roxithromycin (RXM), which is a new 14-member macrolide antibiotic, has a wide antibacterial spectrum against oral pathogens and an immunomodulatory effect. In the present study, we examined the effects of RXM on tumor necrosis factor (TNF)-alpha-induced vascular endothelial growth factor (VEGF) in human periodontal ligament (HPDL) cells. In addition, the effect of RXM on VEGF expression in HPDL cells was examined. HPDL cells were plated at 5 x 10(5) cells/ml in 150 cm2 cell culture dishes. The confluent-stage cells were pretreated with or without 10 microg/ml of RXM or other antibiotics in 1% FBS-containing alpha-MEM for 24 hours, followed by simultaneous treatment with 10 ng/ml of TNF-alpha and 10 microg/ml of these antibiotics. After incubation for various periods, the culture supernatants and sediments were collected and analyzed by ELISA, Northern blot, and gel shift assays. VEGF mRNA and its protein were constitutively expressed in HPDL cells, and the level of expression was markedly enhanced by stimulation with TNF-alpha. RXM strongly inhibited the expression of VEGF mRNA and the production of VEGF. Furthermore, RXM suppressed activation of transcription factors AP-1 and SP-1, which were critical factors in VEGF transcription, in TNF-alpha-stimulated HPDL cells. These results indicate that TNF-alpha, one of the proinflammatory cytokines implicated in the pathogenesis of periodontitis, induces excess induction of VEGF in HPDL, which may account for increased angiogenesis in periodontitis lesions. Interestingly, the antibiotic roxithromycin inhibits TNF-mediated VEGF induction, suggesting its possible therapeutic utility in periodontitis and other chronic inflammatory conditions involving VEGF induction.Keywords
This publication has 48 references indexed in Scilit:
- A New Member of Tumor Necrosis Factor Ligand Family, ODF/OPGL/TRANCE/RANKL, Regulates Osteoclast Differentiation and FunctionBiochemical and Biophysical Research Communications, 1999
- Normoxic Wound Fluid Contains High Levels of Vascular Endothelial Growth FactorAnnals of Surgery, 1998
- Complete Remission of Metastatic Cervical Cancer with the Angiogenesis Inhibitor TNP-470New England Journal of Medicine, 1998
- Angiogenesis and the Expression of Vascular Endothelial Growth Factor in Endometrium and PlacentaAmerican Journal of Reproductive Immunology, 1997
- Tumor necrosis factor-α induces transcription of the colony-stimulating factor-1 gene in murine osteoblastsJournal of Cellular Physiology, 1996
- The subgingival microflora and gingival crevicular fluid cytokines in refractory periodontitisJournal of Clinical Periodontology, 1995
- LPS Responsiveness in Periodontal Ligament Cells is Regulated by Tumor Necrosis Factor-αJournal of Dental Research, 1995
- The use of angiostatic steroids to inhibit cartilage destruction in anin vivo model of granuloma-mediated cartilage degradationInflammation Research, 1993
- Macrolide antibiotics as antiinflammatory agents: Roxithromycin in an unexpected roleInflammation Research, 1993
- Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growthNature, 1990